DBVT News and Press, DBV Technologies S.A. From 06/02/20

Montrouge, France, June 2, 2020 DBV Technologies To Present at the Goldman Sachs 41 st Annual Global Healthcare Conference DBV Technologies (Euronext: DBV – ISIN: FR0010417345 – Nasdaq Stock Market: DBVT), a clinical-stage biopharmaceutical company, today announced th...

ShiftPixy PIXY  -27%  after pricing ~$12M public offering. More news on: GigaMedia Limited, Renren Inc., DBV Technologies S.A., Stocks on the move, , Read more ...

 Gainers: Nano Dimension NNDM  +272% . More news on: ShiftPixy, Inc., Mercurity Fintech Holding Inc., Iterum Therapeutics plc, Stocks on the move, , Read more ...

Information regarding the total number of voting rights and total number of shares of the Company as of April 30, 2020 (Article 223-16 of the General Regulations of the Autorité des Marchés Financiers ) Market : NYSE Euronext Paris ISIN Code: FR 0010417345 ...

COVID-19 Is Distracting Investors from an Amazing Market Opportunity While the world remains hyper-focused on COVID-19 as the biggest healthcare challenge of the past century, it is perhaps easy to overlook progress being made to treat more mundane (yet far more durable) medical problems. ...

DBVT Technologies (NASDAQ: DBVT ) files an offer to sell ordinary shares of an indeterminate amount. More news on: DBV Technologies S.A., Tech stocks news, , Read more ...

Montrouge, France, April 30, 2020 DBV Technologies Reports March 31, 2020 Cash Position DBV Technologies (Euronext: DBV – ISIN: FR0010417345 – Nasdaq Stock Market: DBVT), a clinical-stage biopharmaceutical company, today announced its cash and cash equivalents and its n...

LMP Automotive Holdings (NASDAQ: LMPX ) +35% . More news on: LMP Automotive Holdings, Inc., AgEagle Aerial Systems, Inc., Soligenix, Inc., Stocks on the move, , Read more ...

Aimmune Therapeutics ( AIMT ) was a stock I followed and invested in and also recommended to my subscribers before the approval. The stock did double over a period of 6 months, however, there were some jittery moments right before Palforzia’s (AR101) approval with unscheduled delays and...

Montrouge, France, April 20, 2020 DBV Technologies Announces Results of its 2020 Ordinary and Extraordinary General Meeting Shareholders approve all proposed resolutions DBV Technologies (Euronext: DBV – ISIN: FR0010417345 – Nasdaq Stock Market: DBVT), a clinical-stage...